SCHEMBL15095003

SCHEMBL15095003

CCOn1c(=O)c2sccc2c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
PKM P14618 1/20 0.49
ALDH1A1 P00352 7/20 0.48
TSHR P16473 1/20 0.48
KMT2A Q03164 5/20 0.45
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 2/20 0.40
ADORA1 P30542 3/20 0.39
ADORA3 P0DMS8 1/20 0.39
GLA P06280 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ADORA2A P29274 1/20 0.36
PGR P06401 1/20 0.36
RORA P35398 1/20 0.36
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2553283 0.84 SMN1; SMN2 (0.53) ALDH1A1KMT2AKDM4ESMN1; SMN2POLB
Hydrochloric Acid SCHEMBL2550119 0.82 SMN1; SMN2 (0.51) ALDH1A1KMT2AKDM4ESMN1; SMN2POLB
Hydrochloric Acid SCHEMBL2550919 0.77 KMT2A (0.53) LMNAPKMALDH1A1KMT2AKDM4E
SCHEMBL27772278 0.76 LMNA (0.50) LMNAPKMALDH1A1TSHRKMT2A
SCHEMBL2553123 0.75 GPR3 (0.50) LMNAALDH1A1KMT2AKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL14672734 0.74 GPR3 (0.48) LMNAALDH1A1KMT2AKDM4ESMN1; SMN2
Bromide SCHEMBL16858710 0.74 GPR3 (0.48) LMNAALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL2549113 0.72 KDM4E (0.47) LMNAPKMALDH1A1KMT2AKDM4E
Hydrochloric Acid SCHEMBL2553176 0.71 KDM4E (0.46) LMNAPKMALDH1A1KMT2AKDM4E
Hydrochloric Acid SCHEMBL2571838 0.69 KDM4E (0.52) LMNAPKMALDH1A1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962648-B2 Tricyclic compounds and PBK inhibitors containing the same ONCOTHERAPY SCIENCE, INC. (JP) 2015-02-24 US disclosed
US-20130178459-A1 TRICYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178459-A1 TRICYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME PBDC1, SBK1, PLK2 LMNA 1265/4885PKM 338/4885ALDH1A1 4033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.